Publication date: November 2026 Source: Clinical Lung Cancer, Volume 27, Issue 9 Author(s): Jonathan W. Goldman, Jonathan W. Riess, Byoung Chul Cho, Sarah B. Goldberg, Xiuning Le, Zofia Piotrowska, Isamu Okamoto, Helena A. Yu, Rosario García-Campelo, Javier de Castro Carpeño, Simon Ekman, Noemi Reguart, Marthe S. Paats, Sang-We Kim, Yu Jung Kim, Makoto Nishio, Kristen A. Marrone, Knut B. Smeland, Lizza E.L. Hendriks, Hiroaki Akamatsu
Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD. // Clinical Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1525730426001191?dgcid=rss_sd_all
Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD. Clinical Lung Cancer. https://www.sciencedirect.com/science/article/pii/S1525730426001191?dgcid=rss_sd_all
“Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD.” Clinical Lung Cancer.
@article{article40891,
title = {Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD},
journal = {Clinical Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1525730426001191?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment